Literature DB >> 1086250

Expression of a receptor for IgM by human T cells in vitro.

L Moretta, M Ferrarini, M L Durante, M C Mingari.   

Abstract

The capacity of human peripheral blood lymphocytes (PBL) to bind antigen-IgG antibody (EA(IgG)) and antigen-IgM antibody (EA(IgM)) complexes was investigated using a rosette technique with ox erythrocytes coated with rabbit IgG or IgM antibody. It was found that while EA(IgG)-rosette-forming cells (RFC) were detected on PBL freshly drawn from normal individuals, EA(IgM)-RFC were present only in suspensions kept in culture for 24 h in mediá supplemented with sera containing very low or no amounts of IgM. Experiments of simultaneous detection of EA(IgG)-RFC or EA(IgM)-RFC and other membrane markers for human T or B cells together with experiments on purified T or B cell populations indicated that EA(IgG)-RFC were formed by both T and B cells, while T cells only were capable of EA(IgM) rosette formation. The specificity of the receptors for IgG and IgM was determined by studying the inhibitory capacity of purified human IgM and IgG in the rosette assay. The receptor for IgG was inhibited by IgG and not by IgM, while the reverse was true for the receptor for IgM.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1086250     DOI: 10.1002/eji.1830050812

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  121 in total

1.  Evidence for the presence of a receptor for IgM on the pathological cells of Sézary's syndrome.

Authors:  C P Worman; G F Burns; C R Barker
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

2.  Differential sensitivity of lymphocyte subpopulations to suppression by low density lipoprotein inhibitor, an immunoregulatory human serum low density lipoprotein.

Authors:  L K Curtiss; T S Edgington
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

3.  Generation of virus-specific cytolytic activity in human peripheral lymphocytes after vaccination with vaccinia virus and measles virus.

Authors:  L H Perrin; D Reynolds; R Zinkernagel; M B Oldstone
Journal:  Med Microbiol Immunol       Date:  1978-11-17       Impact factor: 3.402

4.  FcμR in human B cell subsets in primary selective IgM deficiency, and regulation of FcμR and production of natural IgM antibodies by IGIV.

Authors:  Sudhir Gupta; Sudhanshu Agrawal; Sastry Gollapudi; Hiromi Kubagawa
Journal:  Hum Immunol       Date:  2016-10-14       Impact factor: 2.850

5.  Receptors for IgM on human lymphocytes. II. Mitogen-induced modulation of receptor expression.

Authors:  P M Lydyard; M W Fanger
Journal:  Clin Exp Immunol       Date:  1979-09       Impact factor: 4.330

6.  Subpopulations of lymphocytes in human thymomas.

Authors:  L Lauriola; M Piantelli; A Carbone; M A Dina; C Scoppetta; P Musiani
Journal:  Clin Exp Immunol       Date:  1979-09       Impact factor: 4.330

7.  Subpopulations of T lymphocytes in myasthenia gravis patients.

Authors:  M Piantelli; L Lauriola; A Carbone; A Evoli; P Tonali; P Musiani
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

8.  Receptors for IgA on a subpopulation of human B lymphocytes.

Authors:  S Gupta; C D Platsoucas; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

9.  Characterization of the receptor for IgM present on human B lymphocytes.

Authors:  G F Burns; J C Cawley; C R Barker
Journal:  Immunology       Date:  1979-03       Impact factor: 7.397

10.  T-cell nature of leukaemic cells in a case of Sézary's syndrome with 'null-cell' features.

Authors:  L Lauriola; P Musiani; A Carbone; M Bartolini; P Cianciulli; M Piantelli
Journal:  J Clin Pathol       Date:  1979-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.